» Articles » PMID: 16674979

Mutational Analysis of the Cu/Zn Superoxide Dismutase Gene in a Catalan ALS Population: Should All Sporadic ALS Cases Also Be Screened for SOD1?

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2006 May 6
PMID 16674979
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: SOD1 gene mutations are the most common identified cause of ALS, accounting for approximately 20% of familial ALS cases and around 4% of sporadic ALS cases. However, the prevalence of SOD1 varies in different ethnic groups. No previous epidemiological studies have been carried out in Catalonia.

Objective: To determine the prevalence of SOD1 gene mutations in a Catalan ALS population, and to analyze the genotype-phenotype relationship.

Materials And Methods: 30 different FALS pedigrees and 94 sporadic ALS patients were screened for SOD1 mutations using direct sequence analysis.

Results: Five of the 30 FALS pedigrees (16.6%) carried a SOD1 mutant. The mutations identified in this group were G37R, D76V, S105L, I112M and N139H. Four SOD1 mutants (4.25%) were found in the sporadic ALS group (SALS). The overall frequency (FALS plus SALS) of SOD1 mutations in our series was 6.45%. In the SALS group, D90A was identified in a patient presenting the typical Scandinavian phenotype. A 53-year-old woman with no family history of ALS carried the N139H mutation. Two unrelated sporadic ALS cases carried the A140A SOD1 mutant.

Conclusions: The prevalence of the SOD1 mutation in FALS in Catalonia is similar to levels in other Mediterranean countries, but lower than those in reports studying the Belgian, Japanese, and Scottish populations. The prevalence of the SOD1 mutation was 4.25% in patients with no family history of ALS. These results may have significant repercussions on genetic counseling, and screening for the SOD1 mutation in sporadic ALS cases must therefore be considered.

Citing Articles

Associations Between Diabetes Mellitus and Neurodegenerative Diseases.

Szablewski L Int J Mol Sci. 2025; 26(2).

PMID: 39859258 PMC: 11765393. DOI: 10.3390/ijms26020542.


Superoxide dismutase and neurological disorders.

Chidambaram S, Anand N, Varma S, Ramamurthy S, Vichitra C, Sharma A IBRO Neurosci Rep. 2024; 16:373-394.

PMID: 39007083 PMC: 11240301. DOI: 10.1016/j.ibneur.2023.11.007.


Effects of Pathogenic Mutants of the Neuroprotective RNase 5-Angiogenin in Amyotrophic Lateral Sclerosis (ALS).

Gotte G Genes (Basel). 2024; 15(6).

PMID: 38927674 PMC: 11202570. DOI: 10.3390/genes15060738.


Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo.

Yuan Y, Bailey J, Rivera-Lopez G, Atchison W Neurotoxicology. 2023; 100:72-84.

PMID: 38065418 PMC: 10877233. DOI: 10.1016/j.neuro.2023.12.002.


Unveiling the SOD1-mediated ALS phenotype: insights from a comprehensive meta-analysis.

Domi T, Schito P, Sferruzza G, Russo T, Pozzi L, Agosta F J Neurol. 2023; 271(3):1342-1354.

PMID: 37930481 DOI: 10.1007/s00415-023-12074-6.